Royal Bank of Canada Sells 18,419 Shares of Chemed Corporation $CHE

Royal Bank of Canada trimmed its holdings in Chemed Corporation (NYSE:CHE) by 46.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,852 shares of the company’s stock after selling 18,419 shares during the quarter. Royal Bank of Canada owned about 0.16% of Chemed worth $7,878,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in CHE. Monetary Solutions Ltd bought a new stake in Chemed in the fourth quarter worth approximately $25,000. Los Angeles Capital Management LLC acquired a new position in Chemed in the fourth quarter valued at approximately $26,000. BOK Financial Private Wealth Inc. bought a new position in shares of Chemed during the 4th quarter worth approximately $27,000. Global Retirement Partners LLC boosted its holdings in shares of Chemed by 200.0% during the 4th quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock worth $37,000 after buying an additional 58 shares in the last quarter. Finally, Rothschild Investment LLC grew its position in shares of Chemed by 800.0% during the 4th quarter. Rothschild Investment LLC now owns 108 shares of the company’s stock worth $46,000 after buying an additional 96 shares during the period. Institutional investors own 95.85% of the company’s stock.

Insider Buying and Selling

In other news, Director Patrick P. Grace sold 190 shares of the company’s stock in a transaction dated Friday, July 31st. The stock was sold at an average price of $532.00, for a total transaction of $101,080.00. Following the sale, the director directly owned 3,533 shares in the company, valued at $1,879,556. This represents a 5.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Andrea R. Lindell sold 1,347 shares of the stock in a transaction dated Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the sale, the director directly owned 4,578 shares in the company, valued at approximately $2,047,876.74. The trade was a 22.73% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 3,537 shares of company stock valued at $1,782,654. Corporate insiders own 3.33% of the company’s stock.

Chemed Price Performance

CHE opened at $549.52 on Tuesday. The firm has a 50-day moving average price of $480.51 and a 200-day moving average price of $440.46. Chemed Corporation has a twelve month low of $365.20 and a twelve month high of $557.00. The company has a quick ratio of 0.89, a current ratio of 0.91 and a debt-to-equity ratio of 0.17. The company has a market capitalization of $7.18 billion, a price-to-earnings ratio of 27.60, a PEG ratio of 2.09 and a beta of 0.51.

Chemed (NYSE:CHE) last released its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, topping the consensus estimate of $5.60 by $0.46. The company had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. Chemed’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same period last year, the firm earned $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Equities analysts expect that Chemed Corporation will post 23.18 EPS for the current year.

Chemed Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be paid a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date is Monday, August 17th. This is a positive change from Chemed’s previous quarterly dividend of $0.60. Chemed’s dividend payout ratio is presently 12.05%.

Analysts Set New Price Targets

CHE has been the subject of several research analyst reports. Wall Street Zen upgraded shares of Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. Bank of America restated a “neutral” rating on shares of Chemed in a report on Wednesday, July 29th. Oppenheimer lifted their price target on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research note on Friday, July 31st. Royal Bank Of Canada increased their price objective on shares of Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 30th. Finally, Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, Chemed presently has a consensus rating of “Hold” and an average price target of $530.75.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.